Advertisement

Digestive Diseases and Sciences

, Volume 53, Issue 7, pp 1818–1823 | Cite as

Evaluation of Gastric Cancer Risk Using Topography of Histological Gastritis: A Large-scaled Cross-sectional Study

  • Shinobu Imagawa
  • Masaharu Yoshihara
  • Masanori ItoEmail author
  • Shigeto Yoshida
  • Yoshihiro Wada
  • Masana Tatsugami
  • Akemi Takamura
  • Shinji Tanaka
  • Ken Haruma
  • Kazuaki Chayama
Original Paper

Abstract

We evaluated the topography of histological gastritis, which may be risk factors for gastric cancer (GCa). A total of 530 Helicobacter pylori-positive patients underwent diagnostic upper-gastrointestinal endoscopy. Biopsy specimens were obtained from the gastric antrum and body to assess the grade of gastritis. Subjects were divided into four groups by the topography of active gastritis (antrum predominant gastritis, AP; pan-gastritis with or without corpus atrophy, Pan-1 and Pan-2; and corpus predominant gastritis, CP). A higher prevalence of GCa followed the order of Pan 2→CP→Pan 1→AP. The age of patients decreased in the same order. When we set Pan 2 and CP as a high-risk group, the sensitivity and specificity for GCa detection were 77.3 and 54.7%, which were superior to the serum criteria using pepsinogens. These suggest that topography of histologic gastritis is an important marker to identify the high-risk group.

Keywords

Gastritis Updated Sydney system Pepsinogen Gastric cancer 

Notes

Acknowledgements

We thank Ms. Nao Kubota (Hiroshima University, Japan) for the excellent assistance in the production of the database used in this study. This study was supported by grant from Tsuchiya Research Foundation.

References

  1. 1.
    Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311–1314PubMedCrossRefGoogle Scholar
  2. 2.
    Morris A, Nicholson G (1987) Infection of Campylobacter pylori causes gastritis and raised fasting gastric pH. Am J Gastroenterol 82:192–199PubMedGoogle Scholar
  3. 3.
    Wotherspoon AC, Doglioni C, de Boni M, Spencer J, Isaacson PG (1994) Antibiotic treatment for low-grade gastric MALT lymphoma. Lancet 343:1503PubMedCrossRefGoogle Scholar
  4. 4.
    Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, Yoshikawa A, Yanaoka K, Arii K, Tamai H, Shimizu Y, Takeshita T, Mohara O, Ichinose M (2004) Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 109:138–143PubMedCrossRefGoogle Scholar
  5. 5.
    Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, Festen HP, Meuwissen SG (1995) Long-term sequelae of Helicobacter pylori gastritis. Lancet 345:1525–1528PubMedCrossRefGoogle Scholar
  6. 6.
    Goto T, Haruma K, Kitadai Y, Ito M, Yoshihara M, Sumii K, Kajiyama G (1999) Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients. Clin Cancer Res 5:1411–1415PubMedGoogle Scholar
  7. 7.
    Hiyama T, Haruma K, Kitadai Y, Masuda H, Miyamoto M, Tanaka S, Yoshihara M, Shimamoto F, Chayama K (2002) K-ras mutation in Helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer. Int J Cancer 97:562–566PubMedCrossRefGoogle Scholar
  8. 8.
    Kodama K, Sumii K, Kawano M, Kido T, Nojima K, Sumii M, Haruma K, Yoshihara M, Chayama K (2003) Gastic juice nitrite and vitamin C in patients with gastric cancer and atrophic gastritis: is low acidity solely responsible for cance risk. Eur J Gastroenterol Hepatol 15:987–993PubMedCrossRefGoogle Scholar
  9. 9.
    Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ (2001) Helicobacter pylori infection and the development of gastric cancer: N Engl J Med 345:784–789PubMedCrossRefGoogle Scholar
  10. 10.
    Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. the updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 20:1161–1181PubMedCrossRefGoogle Scholar
  11. 11.
    Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumii K, Kajiyama G (1996) Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol 91:959–962PubMedGoogle Scholar
  12. 12.
    Haruma K, Kawaguchi H, Kohmoto K, Okamoto S, Yoshihara M, Sumii K, Kajiyama G (1995) Helicobacter pylori infection, serum gastrin, and gastric acid secretion in teen-age subjects with duodemal ulcer, gastritis, or normal mucosa. Scand J Gastroenterol 30:322–326PubMedCrossRefGoogle Scholar
  13. 13.
    Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, Komoto K, Tanaka S, Kajiyama G (1998) Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 93:1090–1096PubMedCrossRefGoogle Scholar
  14. 14.
    Kodoi A, Yoshihara M, Sumii K, Haruma K, Kajiyama G (1995) Serum pepsinogen in screening for gastric cancer. J Gastroenterol 30:452–460PubMedCrossRefGoogle Scholar
  15. 15.
    Nishibayashi H, Kanayama S, Kiyohara T, Yamamoto K, Miyazaki Y, Yasunaga Y, Shinomura Y, Takeshita T, Takeuchi T, Morimoto K, Matsuzawa Y (2003) Helicobacter pylori-induced enlarged-fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma. J Gastroenterol Hepatol 18:1384–1391PubMedCrossRefGoogle Scholar
  16. 16.
    Miyamoto M, Haruma K, Yoshihara M, Sumioka M, Nishisaka T, Tanaka S, Inoue K, Chayama K (2002) Five cases of nodular gastritis and gastric cancer: a possible association between nodular gastritis and gastric cancer. Dig Liver Dis 34:819–820PubMedCrossRefGoogle Scholar
  17. 17.
    Chen XY, van der Hulst RW, Bruno MJ, van der Ende A, Xiao SD, Tytgat GN, Ten Kate FJ (1999) Interobserver variation in the histopathological scoring of Helicobacter pylori related gastritis. J Clin Pathol 52:612–615PubMedCrossRefGoogle Scholar
  18. 18.
    Aydin O, Egilmez R, Karabacak T, Kanik A (2003) Interobserver variation in histopathological assessment of Helicobacter pylori gastritis. World J Gastroenterol 9:2232–2235PubMedGoogle Scholar
  19. 19.
    Kim S, Haruma K, Ito M, Tanaka S, Yoshihara M, Chayama K (2004) Magnifying gastroendoscopy for diagnosis of histologic gastritis in the gastric antrum. Dig Liver Dis 36:286–291PubMedCrossRefGoogle Scholar
  20. 20.
    Vaananen H, Vauhkonen M, Helske T, Kaariainen I, Rasmussen M, Tunturi-Hihnala H, Koskenpato J, Sotka M, Turunen M, Sandstrom R, Ristikankare M, Jussila A, Sipponen P (2003) Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 15:885–891PubMedCrossRefGoogle Scholar
  21. 21.
    Mardh E, Mardh S, Mardh B, Borch K (2002) Diagnosis or gastritis by means of a combination of serological analyses. Clin Chim Acta 320:17–27PubMedGoogle Scholar
  22. 22.
    Chiba T, Seno H, Marusawa H, Wakatsuki Y, Okazaki K (2006) Host factors are important in determining clinical outcomes of Helicobacter pylori infection. J Gastroenterol 41:1–9PubMedCrossRefGoogle Scholar
  23. 23.
    Komoto K, Haruma K, Kamada T, Tanaka S, Yoshihara M, Sumii K, Kajiyama G (1998) Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol 93:1271–1276PubMedCrossRefGoogle Scholar
  24. 24.
    Naito Y, Ito M, Watanabe T, Suzuki H (2005) Biomarkers in patients with gastric inflammation: a systematic review. Digestion 72:164–180PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Shinobu Imagawa
    • 1
  • Masaharu Yoshihara
    • 2
  • Masanori Ito
    • 1
    Email author
  • Shigeto Yoshida
    • 3
  • Yoshihiro Wada
    • 1
  • Masana Tatsugami
    • 1
  • Akemi Takamura
    • 1
  • Shinji Tanaka
    • 3
  • Ken Haruma
    • 4
  • Kazuaki Chayama
    • 1
  1. 1.Department of Medicine and Molecular Science, Graduate School of Biomedical SciencesHiroshima UniversityHiroshimaJapan
  2. 2.Health Service CenterHiroshima UniversityHigashi-HiroshimaJapan
  3. 3.Department of EndoscopyHiroshima University HospitalHiroshimaJapan
  4. 4.Division of Gastroenterology, Department of Internal MedicineKawasaki Medical SchoolKurashikiJapan

Personalised recommendations